Neumora Therapeutics (NMRA) Operating Profit

NMRA Annual Operating Profit

-$252.10 M
-$116.23 M-85.54%

31 December 2023

NMRA Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NMRA Quarterly Operating Profit

-$76.65 M
-$12.82 M-20.09%

30 September 2024

NMRA Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NMRA TTM Operating Profit

-$314.55 M
-$19.78 M-6.71%

30 September 2024

NMRA TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NMRA Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-85.5%-27.6%-15.2%
3 y3 years-163.9%-144.8%-12.7%
5 y5 years--144.8%-12.7%

NMRA Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-85.5%at low-188.7%+32.8%-138.8%at low
5 y5-year-163.9%at low-396.3%+57.0%-1510.7%at low
alltimeall time-163.9%at low-396.3%+57.0%-1510.7%at low

Neumora Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Sept 2024
-
-$76.65 M(+20.1%)
-$314.55 M(+6.7%)
June 2024
-
-$63.82 M(+6.2%)
-$294.76 M(+8.0%)
Mar 2024
-
-$60.07 M(-47.3%)
-$273.00 M(+8.3%)
Dec 2023
-$252.10 M(+85.5%)
-$114.00 M(+100.5%)
-$252.10 M(+49.3%)
Sept 2023
-
-$56.86 M(+35.2%)
-$168.81 M(+18.4%)
June 2023
-
-$42.06 M(+7.4%)
-$142.55 M(+8.2%)
Mar 2023
-
-$39.17 M(+27.5%)
-$131.80 M(-3.0%)
Dec 2022
-$135.87 M
-$30.72 M(+0.4%)
-$135.87 M(+3.2%)
DateAnnualQuarterlyTTM
Sept 2022
-
-$30.60 M(-2.3%)
-$131.70 M(-52.8%)
June 2022
-
-$31.31 M(-27.6%)
-$279.23 M(+5.3%)
Mar 2022
-
-$43.24 M(+62.9%)
-$265.11 M(+11.7%)
Dec 2021
-$237.32 M(+148.5%)
-
-
Dec 2021
-
-$26.55 M(-85.1%)
-$237.32 M(+3.0%)
Sept 2021
-
-$178.13 M(+935.6%)
-$230.30 M(+341.4%)
June 2021
-
-$17.20 M(+11.4%)
-$52.17 M(+49.2%)
Mar 2021
-
-$15.45 M(-20.9%)
-$34.97 M(+79.1%)
Dec 2020
-$95.52 M
-$19.53 M
-$19.53 M

FAQ

  • What is Neumora Therapeutics annual operaing income?
  • What is the all time high annual operating profit for Neumora Therapeutics?
  • What is Neumora Therapeutics annual operating profit year-on-year change?
  • What is Neumora Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Neumora Therapeutics?
  • What is Neumora Therapeutics quarterly operating profit year-on-year change?
  • What is Neumora Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Neumora Therapeutics?
  • What is Neumora Therapeutics TTM operating profit year-on-year change?

What is Neumora Therapeutics annual operaing income?

The current annual operating profit of NMRA is -$252.10 M

What is the all time high annual operating profit for Neumora Therapeutics?

Neumora Therapeutics all-time high annual operaing income is -$95.52 M

What is Neumora Therapeutics annual operating profit year-on-year change?

Over the past year, NMRA annual operaing income has changed by -$116.23 M (-85.54%)

What is Neumora Therapeutics quarterly operating income?

The current quarterly operating profit of NMRA is -$76.65 M

What is the all time high quarterly operating profit for Neumora Therapeutics?

Neumora Therapeutics all-time high quarterly operating income is -$15.45 M

What is Neumora Therapeutics quarterly operating profit year-on-year change?

Over the past year, NMRA quarterly operating income has changed by -$16.57 M (-27.59%)

What is Neumora Therapeutics TTM operating income?

The current TTM operating profit of NMRA is -$314.55 M

What is the all time high TTM operating profit for Neumora Therapeutics?

Neumora Therapeutics all-time high TTM operating income is -$19.53 M

What is Neumora Therapeutics TTM operating profit year-on-year change?

Over the past year, NMRA TTM operating income has changed by -$41.54 M (-15.22%)